Results 211 to 220 of about 1,124,073 (259)

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Multimode OAM antenna with reduced beam divergence for 6G networks. [PDF]

open access: yesSci Rep
Rao MV   +7 more
europepmc   +1 more source

Negative-Ion Mode MALDI-TOF MS Combined with Machine Learning for the Rapid Identification of Colistin-Resistant <i>E. cloacae</i> Complex. [PDF]

open access: yesACS Omega
Shi Y   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy